Quince Therapeutics, Inc.
QNCX
$1.22
-$0.04-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -56.47% | -45.06% | -41.61% | -53.41% | -45.66% |
| Total Receivables | 310.66% | 0.00% | 2.90% | -5.66% | -11.18% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.74% | -23.61% | -27.31% | -16.70% | -16.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -54.34% | -42.52% | -51.48% | -24.35% | 546.73% |
| Total Current Assets | -48.01% | -43.54% | -41.13% | -51.97% | -43.14% |
|
|
|||||
| Total Current Assets | -48.01% | -43.54% | -41.13% | -51.97% | -43.14% |
| Net Property, Plant & Equipment | 28.91% | 43.02% | 35.00% | 16.17% | 31.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 12.95% | -0.22% | 14,914.67% | 0.18% | -5.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -82.31% | 7.57% | -84.10% | 16.64% | 12.28% |
| Total Assets | -18.30% | -13.14% | -13.07% | -32.77% | -31.82% |
|
|
|||||
| Total Accounts Payable | -23.42% | 109.80% | -26.86% | 45.31% | 42.79% |
| Total Accrued Expenses | 159.00% | 34.47% | 112.89% | 90.61% | 27.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18,796.88% | 17,359.41% | 19.15% | 9.68% | 50.00% |
| Total Finance Division Other Current Liabilities | 3,983.44% | 48.99% | -96.59% | -95.38% | -92.94% |
| Total Other Current Liabilities | 3,983.44% | 48.99% | -96.59% | -95.38% | -92.94% |
| Total Current Liabilities | 493.93% | 380.07% | -27.65% | -15.06% | -23.97% |
|
|
|||||
| Total Current Liabilities | 493.93% | 380.07% | -27.65% | -15.06% | -23.97% |
| Long-Term Debt | -- | -- | 22.81% | 12.93% | 6.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.24% | -20.22% | -14.57% | -20.21% | 22.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.44% | 35.56% | 27.47% | 5.26% | 4.78% |
| Total Liabilities | 53.25% | 33.40% | 20.05% | 3.99% | 1.83% |
|
|
|||||
| Common Stock & APIC | 3.03% | 2.52% | 2.16% | 1.24% | 1.24% |
| Retained Earnings | -22.31% | -15.65% | -13.68% | -18.35% | -17.78% |
| Treasury Stock & Other | 16,528.57% | 84.06% | 466.33% | 7.23% | -101.15% |
| Total Common Equity | -218.47% | -97.64% | -75.01% | -74.95% | -64.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -218.47% | -97.64% | -75.01% | -74.95% | -64.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -218.47% | -97.64% | -75.01% | -74.95% | -64.57% |
|
|
|||||